News

EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg Engineering

EssilorLuxottica Completes Acquisitionof a Majority Stake in Heidelberg Engineering Paris, France and Heidelberg, Germany (October 2, 2024 – 7am CEST) –…

1 year ago

CARBIOS announces half-year 2024 financial results and presents its industrial and commercial progress

  Construction progress of world’s first PET enzymatic biorecycling plant in France: in line with production targets in 2026Commercial development:…

1 year ago

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority…

1 year ago

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a…

1 year ago

Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to November 3, 2024

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special…

1 year ago

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif.,…

1 year ago

BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement

RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic…

1 year ago

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical…

1 year ago

BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024

LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today…

1 year ago

Kids Help Phone Launches the KHP Innovation and Applied Research Accelerator for Youth Mental Health on the Elevate Stage

The acceleratorKHP will disrupt the future of youth mental health support in Canada TORONTO, Oct. 2, 2024 /CNW/ - Kids…

1 year ago